LOWELL, Mass., April 05, 2016 -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the addition of Steven Raters as Vice President of Global Technical Services. Steven will report directly to the CEO, Robert Spignesi.
Mr. Raters brings over 25 years of customer service experience in the medical device and diagnostics industry. Most recently, he held the position of Senior Director of Service Transformation in Latin America at bioMérieux, where he focused on standardization and optimization of service delivery in a high sales growth region. Mr. Raters held multiple service and operations leadership roles at bioMérieux, including managing a team of almost 200 customer support, field application and field service employees. Mr. Raters’ prior roles included positions at Organon Teknika Corp and with the United Sates Navy.
“I am thrilled to welcome a key leader with experience like Steven to join our executive team,” said CEO Robert Spignesi. “His track record of building high performing service organizations and substantially improving customer satisfaction, revenue and profitability will be instrumental to our continued growth and success.”
“I am pleased to join the team at Rapid Micro Biosystems and take on this assignment during an exciting phase of the company’s development,” said Mr. Raters. “I look forward to building a high quality service organization capable of delivering world-class customer experience.”
Steven holds a B.S. in Business Management and an MBA from the University of Phoenix.
About Rapid Micro Biosystems:
Rapid Micro Biosystems delivers the Growth Direct™ System, an automated, non-destructive rapid detection and enumeration technology based on the compendial method for microbial quality control in pharmaceutical manufacturing. The system automates and accelerates detection and enumeration in the areas of sterility testing, environmental monitoring, and bioburden testing, eliminating manual steps and analysis. The detection technology, first developed and patented by Dr. Don Straus, Ph.D., uses the natural auto-fluorescence of microbes and requires no reagents. For more information about Rapid Micro Biosystems visit www.rapidmicrobio.com
Contact: Eugenia Kendrick Rapid Micro Biosystems [email protected]


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Instagram Outage Disrupts Thousands of U.S. Users 



